Walters (R) - Track Record on Recovery Residences,
aka "Sober Living Homes"
Represenative Mimi Walters (R- 45th Congressional District) has served as:
2004-2008 Assembly Member, California State Assembly
2008-2012 State Senator, California’s 33rd Senate District
2012-2015 State Senator, California’s 37th Senate District
She was elected to U.S. Congress from the 45th Congressional District in 2014, starting in early 2015.
12/19/06 The issue of recovery residences first arose publicly when Rep. Walters was an Assembly Member, more than 10 years ago.
1/12/17 Co-sponsored the bill when Darrell Issa introduced HR 472, the Safe Recovery and Community Empowerment Act.
12/12/17 As a member of the House of Representatives' Subcommittee on Oversight and Investigation in the Committee on Energy and Commerce, attended the hearing entitled “Examining Concerns of Patient Brokering and Addiction Treatment Fraud” (1:30:00). She submitted data about opioid deaths in Orange County and news from the Orange County Register.
After describing abuses in the industry, Rep. Walters asked the following questions of CCAPP CEO Nielsen:
(1:32:40) “It is our understanding that in California the Department of Health Care Services licenses residential or inpatient treatment facilities but does NOT license outpatient treatment facilities, do you know why that is?”
(1:33:40) “Do you know if there are outpatient facilities licensed or overseen by any other body to ensure that these facilities meet standards to ensure safe and effective treatments?”
(1:34:15) “You state that sober living homes serve as a bridge to independent living. That this stage of the recovery process is obviously distinct from inpatient treatment but clearly the patient is not prepared to resume complete independence. Should these sober living homes be subject to licensing?"
12/20/17 Co-sponsored HR 4684, the Access to Quality Sober Living Act which "would require the U.S. Department of Health and Human Services to establish best practices for operating recovery residences, or sober living facilities, to ensure patients receive high quality care.” Became law on 10/26/18.
2004-2008 Assembly Member, California State Assembly
2008-2012 State Senator, California’s 33rd Senate District
2012-2015 State Senator, California’s 37th Senate District
She was elected to U.S. Congress from the 45th Congressional District in 2014, starting in early 2015.
12/19/06 The issue of recovery residences first arose publicly when Rep. Walters was an Assembly Member, more than 10 years ago.
1/12/17 Co-sponsored the bill when Darrell Issa introduced HR 472, the Safe Recovery and Community Empowerment Act.
12/12/17 As a member of the House of Representatives' Subcommittee on Oversight and Investigation in the Committee on Energy and Commerce, attended the hearing entitled “Examining Concerns of Patient Brokering and Addiction Treatment Fraud” (1:30:00). She submitted data about opioid deaths in Orange County and news from the Orange County Register.
After describing abuses in the industry, Rep. Walters asked the following questions of CCAPP CEO Nielsen:
(1:32:40) “It is our understanding that in California the Department of Health Care Services licenses residential or inpatient treatment facilities but does NOT license outpatient treatment facilities, do you know why that is?”
(1:33:40) “Do you know if there are outpatient facilities licensed or overseen by any other body to ensure that these facilities meet standards to ensure safe and effective treatments?”
(1:34:15) “You state that sober living homes serve as a bridge to independent living. That this stage of the recovery process is obviously distinct from inpatient treatment but clearly the patient is not prepared to resume complete independence. Should these sober living homes be subject to licensing?"
12/20/17 Co-sponsored HR 4684, the Access to Quality Sober Living Act which "would require the U.S. Department of Health and Human Services to establish best practices for operating recovery residences, or sober living facilities, to ensure patients receive high quality care.” Became law on 10/26/18.